Collegium Pharmaceutical Inc (COLL)

Operating profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating income	US$ in thousands	169,895	166,961	-104,573	-46,699	-5,086
Revenue	US$ in thousands	631,449	566,767	463,933	276,868	310,016
Operating profit margin		26.91%	29.46%	-22.54%	-16.87%	-1.64%

December 31, 2024 calculation

Operating profit margin = Operating income ÷ Revenue
= $169,895K ÷ $631,449K
= 26.91%

The operating profit margin of Collegium Pharmaceutical Inc has experienced fluctuations over the past few years. It was negative in December 31, 2020, at -1.64%, indicating that the company's operating expenses exceeded its operating income during that period. The margin deteriorated further to -16.87% in December 31, 2021, and continued to decline to -22.54% in December 31, 2022, reflecting increased operating losses relative to revenue.

However, there was a significant turnaround in December 31, 2023, when the operating profit margin improved substantially to 29.46%. This positive shift suggests that Collegium Pharmaceutical Inc effectively managed its operating expenses and generated a healthy operating income compared to revenue during that year. The trend continued into December 31, 2024, with a relatively high operating profit margin of 26.91%, indicating sustained profitability and efficiency in the company's operations.

Overall, the recent improvement in Collegium Pharmaceutical Inc's operating profit margin showcases the company's ability to enhance operational performance and generate higher profits relative to its operating costs. This positive trend is a promising sign of financial health and effective management within the organization.